von Bergmann K - Search Results

1

Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype *17.

Niemi M, Neuvonen PJ, Hofmann U, Backman JT, Schwab M, Lütjohann D, von Bergmann K, Eichelbaum M, Kivistö KT. Niemi M, et al. Among authors: von bergmann k. Pharmacogenet Genomics. 2005 May;15(5):303-9. doi: 10.1097/01213011-200505000-00005. Pharmacogenet Genomics. 2005. PMID: 15864131

2

Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin.

Igel M, Arnold KA, Niemi M, Hofmann U, Schwab M, Lütjohann D, von Bergmann K, Eichelbaum M, Kivistö KT. Igel M, et al. Among authors: von bergmann k. Clin Pharmacol Ther. 2006 May;79(5):419-26. doi: 10.1016/j.clpt.2006.01.010. Epub 2006 Apr 11. Clin Pharmacol Ther. 2006. PMID: 16678544 Clinical Trial.

3

Disposition of oral and intravenous pravastatin in MRP2-deficient TR- rats.

Kivistö KT, Grisk O, Hofmann U, Meissner K, Möritz KU, Ritter C, Arnold KA, Lutjöohann D, von Bergmann K, Klöting I, Eichelbaum M, Kroemer HK. Kivistö KT, et al. Among authors: von bergmann k. Drug Metab Dispos. 2005 Nov;33(11):1593-6. doi: 10.1124/dmd.105.006262. Epub 2005 Aug 17. Drug Metab Dispos. 2005. PMID: 16107564

4

Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levels.

Gerloff T, Schaefer M, Mwinyi J, Johne A, Sudhop T, Lütjohann D, Roots I, von Bergmann K. Gerloff T, et al. Among authors: von bergmann k. Naunyn Schmiedebergs Arch Pharmacol. 2006 Apr;373(1):45-50. doi: 10.1007/s00210-006-0053-6. Epub 2006 Mar 28. Naunyn Schmiedebergs Arch Pharmacol. 2006. PMID: 16568260

5

Influence of simvastatin, pravastatin, and BM 15.766 on neutral sterols in liver and testis of guinea pigs.

Lindenthal B, Bertsch T, Fassbender K, Stroick M, Kühl S, Lütjohann D, von Bergmann K. Lindenthal B, et al. Among authors: von bergmann k. Metabolism. 2002 Apr;51(4):492-9. doi: 10.1053/meta.2002.31341. Metabolism. 2002. PMID: 11912560

6

24S-hydroxycholesterol: a marker of brain cholesterol metabolism.

Lütjohann D, von Bergmann K. Lütjohann D, et al. Among authors: von bergmann k. Pharmacopsychiatry. 2003 Sep;36 Suppl 2:S102-6. doi: 10.1055/s-2003-43053. Pharmacopsychiatry. 2003. PMID: 14574622

7

Inhibition of intestinal cholesterol absorption by ezetimibe in humans.

Sudhop T, Lütjohann D, Kodal A, Igel M, Tribble DL, Shah S, Perevozskaya I, von Bergmann K. Sudhop T, et al. Among authors: von bergmann k. Circulation. 2002 Oct 8;106(15):1943-8. doi: 10.1161/01.cir.0000034044.95911.dc. Circulation. 2002. PMID: 12370217 Clinical Trial.

8

Sterol transporters: targets of natural sterols and new lipid lowering drugs.

Sudhop T, Lütjohann D, von Bergmann K. Sudhop T, et al. Among authors: von bergmann k. Pharmacol Ther. 2005 Mar;105(3):333-41. doi: 10.1016/j.pharmthera.2004.10.011. Epub 2004 Dec 9. Pharmacol Ther. 2005. PMID: 15737409 Review.

9

Cholesterol and plant sterol absorption: recent insights.

von Bergmann K, Sudhop T, Lütjohann D. von Bergmann K, et al. Am J Cardiol. 2005 Jul 4;96(1A):10D-14D. doi: 10.1016/j.amjcard.2005.03.014. Am J Cardiol. 2005. PMID: 15992510 Review.

10

Effect of pravastatin on plasma sterols and oxysterols in men.

Thelen KM, Lütjohann D, Vesalainen R, Janatuinen T, Knuuti J, von Bergmann K, Lehtimäki T, Laaksonen R. Thelen KM, et al. Among authors: von bergmann k. Eur J Clin Pharmacol. 2006 Jan;62(1):9-14. doi: 10.1007/s00228-005-0068-9. Epub 2005 Dec 30. Eur J Clin Pharmacol. 2006. PMID: 16385401 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters